latest news

Imanova implements three PET ligands for neurodegeneration

MIND MAPS ligands smallIn the scope of the MIND MAPS programme Imanova has recently completed the implementation of three P...
read full article

PET imaging agents may allow earlier diagnosis of cardiotoxicity

Cardiotoxity is one of the most important adverse reactions of chemotherapy, significantly reducing ...
read full article

Imanova receives £1m award from the MRC to develop early markers of dementia - the MIND-MAPS study

Following a £0.5m Medical Research Council (MRC) grant to implement new Positron Emission Tomography...
read full article

The power of combining DREADD and PET imaging technologies to be presented for the first time at BrainPET Berlin 2017

neuronsDREADD (Designer Receptors Exclusively Activated by Designer Drugs) technology is an exciting chemog...
read full article

Further Growth in Imanova’s Preclinical Biology Offering

Imanova is pleased to announce further expansion of its preclinical team, with the addition of new r...
read full article